Frontiers in Neurology (Jun 2023)

Case report: Neuronal intranuclear inclusion disease presenting with acute encephalopathy

  • Julia Ting Bu,
  • Dolores Torres,
  • Adam Robinson,
  • Corey Malone,
  • Juan Carlos Vera,
  • Shadi Daghighi,
  • Anastasie Dunn-Pirio,
  • Suzan Khoromi,
  • Justin Nowell,
  • Gabriel C. Léger,
  • Joseph D. Ciacci,
  • Vanessa S. Goodwill,
  • Melanie Estrella,
  • David G. Coughlin,
  • Yueyang Guo,
  • Nikdokht Farid

DOI
https://doi.org/10.3389/fneur.2023.1184612
Journal volume & issue
Vol. 14

Abstract

Read online

Neuronal intranuclear inclusion disease (NIID), a neurodegenerative disease previously thought to be rare, is increasingly recognized despite heterogeneous clinical presentations. NIID is pathologically characterized by ubiquitin and p-62 positive intranuclear eosinophilic inclusions that affect multiple organ systems, including the brain, skin, and other tissues. Although the diagnosis of NIID is challenging due to phenotypic heterogeneity, a greater understanding of the clinical and imaging presentations can improve accurate and early diagnosis. Here, we present three cases of pathologically proven adult-onset NIID, all presenting with episodes of acute encephalopathy with protracted workups and lengthy time between symptom onset and diagnosis. Case 1 highlights challenges in the diagnosis of NIID when MRI does not reveal classic abnormalities and provides a striking example of hyperperfusion in the setting of acute encephalopathy, as well as unique pathology with neuronal central chromatolysis, which has not been previously described. Case 2 highlights the progression of MRI findings associated with multiple NIID-related encephalopathic episodes over an extended time period, as well as the utility of skin biopsy for antemortem diagnosis.

Keywords